Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon?

Coronavirus 2019 disease (COVID-19) is associated with coagulation dysfunction that predisposes patients to an increased risk for both arterial (ATE) and venous thromboembolism (VTE) and consequent poor prognosis; in particular, the incidence of ATE and VTE in critically ill COVID-19 patients can re...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavoni, Vittorio, Gianesello, Lara, Horton, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109223/
https://www.ncbi.nlm.nih.gov/pubmed/33973157
http://dx.doi.org/10.1007/s11239-021-02470-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109223/
https://www.ncbi.nlm.nih.gov/pubmed/33973157
http://dx.doi.org/10.1007/s11239-021-02470-y

Ejemplares similares